tiprankstipranks
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
US Market
Want to see MAYNF full AI Analyst Report?

Mayne Pharma Group (MAYNF) Financial Statements

25 Followers

Mayne Pharma Group Financial Overview

Mayne Pharma Group's market cap is currently $142.87M. The company's EPS TTM is $-0.1034697; its P/E ratio is -4.23; Mayne Pharma Group is scheduled to report earnings on February 22, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total RevenueAU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78M
Gross ProfitAU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02M
Operating IncomeAU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88MAU$ 1.36M
EBITDAAU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40M
Net IncomeAU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29MAU$ -208.42M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 100.40MAU$ 149.28MAU$ 220.14MAU$ 97.08MAU$ 98.35M
Total AssetsAU$ 1.01BAU$ 1.14BAU$ 1.25BAU$ 1.30BAU$ 1.48B
Total DebtAU$ 41.27MAU$ 38.82MAU$ 47.51MAU$ 413.67MAU$ 346.82M
Net DebtAU$ -18.57MAU$ -71.25MAU$ -54.21MAU$ 316.59MAU$ 248.47M
Total LiabilitiesAU$ 644.32MAU$ 688.99MAU$ 613.77MAU$ 764.89MAU$ 706.56M
Stockholders' EquityAU$ 370.28MAU$ 454.19MAU$ 634.36MAU$ 545.88MAU$ 768.36M
Cash Flow
Free Cash FlowAU$ 5.19MAU$ -36.16MAU$ -262.71MAU$ -28.47MAU$ 22.16M
Operating Cash FlowAU$ 17.47MAU$ -15.30MAU$ -43.12MAU$ -16.62MAU$ 47.26M
Investing Cash FlowAU$ -68.07MAU$ 53.45MAU$ 473.49MAU$ -28.53MAU$ -49.25M
Financing Cash FlowAU$ -556.00KAU$ -19.85MAU$ -431.48MAU$ 27.60MAU$ -28.83M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

Mayne Pharma Group Debt to Assets

Mayne Pharma Group Cash Flow

Mayne Pharma Group Forecast EPS vs Actual EPS